Floatz logo

112 assets in Hormone Receptor-Positive Breast Cancer

Therapeutic assets addressing Hormone Receptor-Positive Breast Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
hlx22
Hormone Receptor-Positive Breast Cancer
Shanghai Henlius BiotechP2CCC (53)
Hyaluronidase Zzxf
Hormone Receptor-Positive Breast Cancer
Baylor Breast Care CenterP2CCC (53)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Shr-1805 ?1-Chain), Complex With Human-Mus Musculus Monoclonal Shr-1805 ?-Chain, Dimer, Thioether With N-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]Glycylglycyl-L-Phenylalanyl-N-[[(1R)-1-Cyclopropyl-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-2-Oxoethoxy]Methyl]Glycinamide
Hormone Receptor-Positive Breast Cancer
Tang-Du HospitalP2CCC (53)
Lenvatinib
Hormone Receptor-Positive Breast Cancer
National Cancer Centre, SingaporeP2CCC (53)
Loperamide
Hormone Receptor-Positive Breast Cancer
Spanish Breast Cancer Research GroupP2CCC (53)
Neratinib
Hormone Receptor-Positive Breast Cancer
Spanish Breast Cancer Research GroupP2CCC (53)
sc-101
Hormone Receptor-Positive Breast Cancer
Tianjin ConjuStar Biologics Co., Ltd.P2CCC (53)
Serplulimab
Hormone Receptor-Positive Breast Cancer
Henan Cancer HospitalP2CCC (53)
Shr-A1921
Hormone Receptor-Positive Breast Cancer
Fudan UniversityP2CCC (53)
Sry-Box Transcription Factor 2
Hormone Receptor-Positive Breast Cancer
University of WashingtonP2CCC (53)
Tirzepatide
Hormone Receptor-Positive Breast Cancer
Universitaire Ziekenhuizen KU LeuvenP2CCC (53)
Yb-1
Hormone Receptor-Positive Breast Cancer
University of WashingtonP2CCC (53)
Repotrectinib
Hormone Receptor-Positive Breast Cancer
M.D. Anderson Cancer CenterP2CCC (52)
Rezatapopt
Hormone Receptor-Positive Breast Cancer
PMV Pharmaceuticals, IncP1/2CCC (48)
68ga-r10602
Hormone Receptor-Positive Breast Cancer
Radionetics OncologyP1CC (47)
Amxt 1501 Dicaprate
Hormone Receptor-Positive Breast Cancer
Aminex Therapeutics, Inc.P1/2CC (47)
Avutometinib
Hormone Receptor-Positive Breast Cancer
Adrienne G. WaksP1/2CC (47)
Eflornithine
Hormone Receptor-Positive Breast Cancer
Aminex Therapeutics, Inc.P1/2CC (47)
ep0062
Hormone Receptor-Positive Breast Cancer
Ellipses PharmaP1/2CC (47)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Klrb1 (Killer Cell Lectin Like Receptor B1, Nkr-P1A, Natural Killer Cell Surface Protein P1A, Clec5B, Cd161)], Homo Sapiens Monoclonal Antibody; Gamma1 Heavy Chain Homo Sapiens (1-450) [Vh (Homo Sapiens Ighv3-23*01 (96.9%) -(Ighd) -Ighj4*01 (85.7%), Q120>R (113), Cdr-Imgt [8.8.14] (26-33.51-58.97-110)) (1-121) -Homo Sapiens Ighg1*01, G1M17,1 Ch1 K120, Ch3 D12, L14, G1V29 Ch2 A84.4 (Ch1 K120 (218) (122-219), Hinge 1-15 (220-234), Ch2 G1V29 Ch2 N84.4>A (301) (235-344), Ch3 D12 (360), L14 (362) (345-449), Chs K2>Del (450)) (122-450)], (224-214')-Disulfide With Kappa Light Chain Homo Sapiens (1'-214') [V-Kappa (Homo Sapiens Igkv1-12*01 (94.7%) -Igkj4*01 (91.7%), Cdr-Imgt [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo Sapiens Igkc*01 (100%), Km3, A45.1 (153'), V101 (191') (108'-214')]; Dimer (230-230'':233-233'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-K1 Lacking The Glutamine Synthetase (Gs-Ko) Gene, Non-Glycosylated
Hormone Receptor-Positive Breast Cancer
Immunitas TherapeuticsP1/2CC (47)
Tyk-00540
Hormone Receptor-Positive Breast Cancer
TYK Medicines, IncP1/2CC (47)
BMS986310
Hormone Receptor-Positive Breast Cancer
Ono Pharmaceutical Co., Ltd.P1CC (46)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Hormone Receptor-Positive Breast Cancer
H. Lee Moffitt Cancer Center and Research InstituteP1CC (46)
Avzo-021
Hormone Receptor-Positive Breast Cancer
Avenzo Therapeutics, Inc.P1/2CC (45)
Avzo-023
Hormone Receptor-Positive Breast Cancer
Avenzo Therapeutics, Inc.P1/2CC (45)
Bpi-1178
Hormone Receptor-Positive Breast Cancer
Beta Pharma (Suzhou) Co., Ltd.P1/2CC (45)
177lu-r11228
Hormone Receptor-Positive Breast Cancer
Radionetics OncologyP1CC (43)
[225Ac]Ac-AKY-1189
Hormone Receptor-Positive Breast Cancer
Aktis Oncology, Inc.P1CC (43)
[64Cu]Cu-AKY-1189
Hormone Receptor-Positive Breast Cancer
Aktis Oncology, Inc.P1CC (43)
68ga-r11228
Hormone Receptor-Positive Breast Cancer
Radionetics OncologyP1CC (43)
Abbv-461
Hormone Receptor-Positive Breast Cancer
Calibr, a division of Scripps ResearchP1CC (43)
Atezolizumab
Hormone Receptor-Positive Breast Cancer
ExelixisP1CC (43)
ava6103
Hormone Receptor-Positive Breast Cancer
Avacta Life Sciences LtdP1CC (43)
Bbo-10203
Hormone Receptor-Positive Breast Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)P1CC (43)
bg-68501
Hormone Receptor-Positive Breast Cancer
BeiGeneP1CC (43)
Bgb-21447
Hormone Receptor-Positive Breast Cancer
BeOne MedicinesP1CC (43)
CD47/SIRPA-BLOCKING AGENT ALX148
Hormone Receptor-Positive Breast Cancer
QuantumLeap Healthcare CollaborativeP1CC (43)
Clbr001
Hormone Receptor-Positive Breast Cancer
Calibr, a division of Scripps ResearchP1CC (43)
Copanlisib
Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)P1CC (43)
Datopotamab Deruxtecan
Hormone Receptor-Positive Breast Cancer
Daiichi Sankyo Co., Ltd.P1CC (43)
Eribulin Monomethanesulfonate
Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)P1CC (43)
Fam-Trastuzumab Deruxtecan-Nxki
Hormone Receptor-Positive Breast Cancer
QuantumLeap Healthcare CollaborativeP1CC (43)
Felmetatug Vedotin
Hormone Receptor-Positive Breast Cancer
Seagen, a wholly owned subsidiary of PfizerP1CC (43)
nkt5097 cdk2/cdk4 dual degrader
Hormone Receptor-Positive Breast Cancer
NiKang Therapeutics, Inc.P1CC (43)
Pidnarulex
Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)P1CC (43)
TH19P01-DOCETAXEL
Hormone Receptor-Positive Breast Cancer
TheratechnologiesP1CC (43)
Tolinapant
Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)P1CC (43)
Tucatinib
Hormone Receptor-Positive Breast Cancer
QuantumLeap Healthcare CollaborativeP1CC (43)
xb010
Hormone Receptor-Positive Breast Cancer
ExelixisP1CC (43)
Zanidatamab
Hormone Receptor-Positive Breast Cancer
QuantumLeap Healthcare CollaborativeP1CC (43)
Showing 51 to 100 of 112 assets
PreviousPage 2 of 3Next